Overview of CRISPR
CRISPR represents a groundbreaking instrument that is altering lives and creating significant impacts in the realm of medicine. CRISPR, an acronym for “Clustered Regularly Interspaced Short Palindromic Repeats,” is present in prokaryotes—tiny, unicellular organisms devoid of organelles. These sequences are situated in the genomes of prokaryotes, which organize a cell’s DNA in clusters.
As a tool for gene editing, CRISPR is utilized to alter particular sections of DNA to address critical diseases. It is especially effective as it aids in defending the organism against viral invasions by integrating the foreign DNA into its own genomic structure, thereby equipping it to identify and eliminate the virus in subsequent encounters. What stands out is that, in contrast to other gene editing techniques, CRISPR is significantly more accurate and simpler to program, facilitating a more straightforward process for redesigning sequences. While other gene-editing methods typically depend on a single protein, CRISPR employs RNA-guided targeting along with the Cas9 enzyme.
Mechanism of CRISPR
CRISPR operates by leveraging a natural defense mechanism present in bacteria that enables them to detect and eradicate viral threats. When a virus penetrates a bacterial cell (a prokaryote), the bacterium retains a portion of the invader’s DNA within its own genome as a sort of genetic “memory.” This allows the bacterium to identify and respond more adeptly to future assaults.
In gene editing applications, this framework is modified with two essential components: the Cas9 enzyme, which acts like molecular scissors to sever DNA, and guide RNA, which directs Cas9 to the precise genetic sequence requiring modification. After the target DNA is cleaved, the cell’s inherent repair mechanisms engage, permitting scientists to implement alterations in the genetic code.
Unlike previous tools that depended on difficult-to-reprogram proteins, CRISPR’s RNA-guided approach is more adaptable, simpler to create, and notably precise. This ease and accuracy have enabled CRISPR’s use in fields such as medicine, agriculture, manufacturing, and microbiology—like engineering microorganisms to enhance production yields. However, as this article discusses, the expansion of capabilities also raises significant ethical dilemmas, especially related to germline modification and genetic enhancement.
The First Patient to Receive Customized CRISPR Treatment
In February 2025, the first-ever personalized CRISPR treatment was administered to an infant named KJ to address a deficiency in Carbamoyl Phosphate Synthetase 1 (CPS1)—an enzyme that plays a crucial role in converting ammonia (produced from protein breakdown) into urea. A research team led by Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunuru at the Children’s Hospital of Philadelphia created this treatment after extensive research in gene editing and partnerships with other healthcare professionals.
Their efforts concentrated on conditions affecting the urea cycle, leading to harmful ammonia accumulation, which can damage organs such as the brain and liver. They specifically tailored the treatment for KJ’s variant of CPS1 deficiency based on preclinical studies on similar conditions.
To date, the only CRISPR therapies endorsed by the U.S. FDA have targeted more prevalent conditions such as sickle cell disease and beta thalassemia, impacting many patients. In KJ’s scenario, his treatment was designed within six months of birth, aimed at his unique CPS1 variant. The team developed a base editing therapy delivered through lipid nanoparticles to his liver to rectify the faulty enzyme.
The February treatment constituted the first of three doses; KJ received the subsequent two in March and April 2025. Up until his last treatment, he has shown no significant adverse effects, demonstrates improved tolerance to dietary protein, and needs reduced medication for ammonia management. Although continuous monitoring will be necessary, Ahrens-Nicklas indicates that the outcomes so far appear optimistic.
Ethical Aspects of CRISPR
Like any innovative technology, CRISPR brings forth intricate ethical